Data as of Jul 25
| -0.15 / -1.13%|
The 5 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 18.00, with a high estimate of 19.00 and a low estimate of 16.00. The median estimate represents a +36.88% increase from the last price of 13.15.
The current consensus among 7 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.